MI Medical Innovation GmbH

MI Medical Innovation GmbH (MI) is a medical device systems concept company, Horizon 2020 SME Instrument Phase 1 champion, especially for hemodynamic monitoring, collaborating mainly with emka MEDICAL (emka-medical.de), at the same location with EU-MDD- Annex-II.3 certificate for sterile and non-sterile pressure transducers and software for display of physiological parameters, with ISO 13485:2016 certificate for more, also temperature, oxygen and lactate sensors, dataloggers, and the scope as in Annex II.3 to bring heart failure monitoring systems to the market.

Cor/log Implant, our novel implantable hemodynamic monitoring system for cardiovascular diseases, is a product family consisting of two product types, semi-impant and full implant. The 1P2O version is awarded with Horizon 2020 SME Instrument Phase 1 grant, with the Phase 2 clinical validation awarded with the Seal of Excellence from EU. Cor/log Implant 1P2O monitors venous pressure, venous oxygen and right atrial oxygen.